'The darkest hour is often just before the dawn'. Like many investors during the pandemic, I was guilty of being too pessimistic. However once Gilead had announced the efficacy of its Remdesivir drug on 29th April (1st medical breakthrough), the clouds began to part. Since then many others have also ‘climbed the wall of worry’, culminating with the recent terrific vaccine news. In fact on Friday, Goldman Sachs upped their UK GDP estimates to 7.0% for next year (vs 6.1% B4) & 6.2% in 2022. 1.9% higher than the 5.1% predicted by the Treasury’s own “poll of experts” last month
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
The stars are aligning
'The darkest hour is often just before the dawn'. Like many investors during the pandemic, I was guilty of being too pessimistic. However once Gilead had announced the efficacy of its Remdesivir drug on 29th April (1st medical breakthrough), the clouds began to part. Since then many others have also ‘climbed the wall of worry’, culminating with the recent terrific vaccine news. In fact on Friday, Goldman Sachs upped their UK GDP estimates to 7.0% for next year (vs 6.1% B4) & 6.2% in 2022. 1.9% higher than the 5.1% predicted by the Treasury’s own “poll of experts” last month